Endothelial activation and stress index ( EASIX ) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment

Documenti analoghi

• Improved early transplant outcomes with reduced‐dose PTCy and low‐dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia
  di: Nihar Desai, et al.
  Pubblicazione: (2026)
• Impact of graft‐versus‐host disease prophylaxis strategies on GvHD ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis
  di: Nihar Desai, et al.
  Pubblicazione: (2025)
• Central Nervous System Manifestations of Graft‐Versus‐Host Disease
  di: Nihar Desai, et al.
  Pubblicazione: (2025)
• Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience
  di: Nihar Desai, et al.
  Pubblicazione: (2024)
• Can we move beyond myeloablative conditioning ( MAC )? A comparison of MAC versus reduced intensity conditioning ( RIC ) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG ‐ PTCy ‐ CSA for GVHD prophylaxis
  di: Ruah Alyamany, et al.
  Pubblicazione: (2025)